Russia’s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential
marketwatch.com · 5小时前
Putin claims Russia has developed the first coronavirus vaccine
Seeking Alpha - Article · 7小时前
备受德国政府支持 新冠疫苗公司CureVac(CVAC.US)本周将登陆纳斯达克
智通财经网 · 7小时前
Liontrust's 3 Sources of Economic Advantages
GuruFocus.com · 23小时前
IPO Update: CureVac Readies Plans For U.S. IPO
Seeking Alpha - Article · 1天前
CureVac aims to raise up to $245 million in U.S. IPO
CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial public stock offering (IPO) on the U.S. Nasdaq.
Reuters · 1天前
5 Stocks in the Spotlight on Trump's Coronavirus Vaccine Optimism
Zacks · 1天前
The Never Coming Stock Market Crash - Smart Money Is Still Waiting, Here's What I Do